Drv et all is there any way we are now able to "back in" our 148 week RWE data into the presentation now that the FDA new protocols have come out? What else would Dr. M be referring to as a catalyst in the upcoming presentations. The only other thing I can think of is maybe the Ph 2b trial design endpoints inclusions. Perhaps more heart related or insomnia endpoints?